Barone, M. V., Henchcliffe, C., Baralle, F. E. and G. Paolella (1989). Cell type specific trans-acting factors are involved in alternative splicing of human fibronectin pre-mRNA. EMBO J 8, 1079-1085.[Medline]
Borsi, L., Balza, E., Allemanni, G. and Zardi, L (1992). Differential expression of the fibronectin isoform containing the ED-B oncofoetal domain in normal human fibroblast cell lines originating from different tissues. Exp. Cell Res 199, 98-105.[Medline]
Borsi, L., Carnemolla, B., Castellani, P., Rosellini, P., Vecchio, D., Alle-manni, G., Chang, S. E., Taylor-Papadimitriou, J., Pande, H. and Zardi, L (1987). Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J. Cell Biol 104, 595-600.[Abstract/Free Full Text]
Burridge, K., Fath, K., Kelly, T., Nuckolls, G. and Turner, C (1988). Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu. Rev. Cell Biol 4, 487-525.
Carley, W. W., Barak, L. S. and Webb, W. W (1981). F-actin aggregates in transformed cells. J. Cell Biol 90, 797-802.[Abstract/Free Full Text]
Carnemolla, B., Balza, E., Siri, A., Zardi, L. and Nicotra, M. R (1989). A tumour-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J. Cell Biol 108, 1139-1148.[Abstract/Free Full Text]
Chen, J. and Chen, W (1987). Fibronectin-degrading proteases from the membranes of transformed cells. Cell 48, 193-203.[Medline]
Chen, W., Older, K., Bernard, B. A. and Chu, F (1984). Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sites. J. Cell Biol 98, 1546-1553.[Abstract/Free Full Text]
Chomczynski, P. and Sacchi, N (1987). Single step method of DNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 162, 156-159.[Medline]
Der, C. J. and Stanbridge, E. J (1978). Lack of correlation between thedecreased expression of cell surface LETS protein and tumorigenicity in human cell hybrids. Cell 15, 1241-1251.[Medline]
Der, C. J., Ash, J. F. and Stanbridge, E. J (1981). Cytoskeletal and transmembrane interactions in the expression of tumorigenicity in human cell hybrids. J. Cell Sci 52, 151-166.[Medline]
DeSimone, D. W., Norton, P. A. and Hynes, R. O (1992). Identification and characterization of alternatively spliced fibronectin mRNAs expressed in early Xenopus embryos. Dev. Biol 149, 357-369.[Medline]
Evans, E. P., Burtenshaw, M. D., Brown, B. B., Hennion, R. and Harris, H (1982). The analysis of malignancy by cell fusion. IX. Re-examination and clarification of the cytogenetic problem. J. Cell Sci 56, 113-130.[Abstract/Free Full Text]
Gallimore, P. H., McDougall, J. K. and Chen, L. B (1977). In vitro traits of adenovirus-transformed cell lines and their relevance to tumorigenicity. Cell 10, 669-678.[Medline]
Giancotti, F. G. and Ruoslahti, E (1990). Elevated levels of the5 1fibronectin receptor suppress the transformed phenotype of chinese hamster ovary cells. Cell 60, 849-859.[Medline]
Gospodarowicz, D., Lepine, J., Massoglia, S. and Wood, I (1984). Comparison of the ability of basement membranes produced by corneal endothelial and mouse-derived endodermal PF-HR-9 cells to support the proliferation and differentiation of bovine kidney tubule epithelial cells in vitro. J. Cell Biol 99, 947-961.[Abstract/Free Full Text]
Harris, H (1988). The analysis of malignancy by cell fusion: the position in 1988. Cancer Res 48, 3302-3306.[Free Full Text]
Harris, H. and Watkins, J. F (1965). Hybrid cells derived from mouse and man; artificial heterokaryons of mammalian cells from different species. Nature 205, 640-646.[Medline]
Hayman, E. G., Engvall, E. and Ruoslahti, E (1981). Concomitant loss of cell surface fibronectin and laminin from transformed rat kidney cells. J. Cell Biol 88, 352-357.[Abstract/Free Full Text]
Humphries, M. J (1990). The molecular basis and specificity of integrin-ligand interactions. J. Cell Sci 97, 585-592.[Free Full Text]
Humphries, M. J., Komoriya, A. Akiyama, S. K,. Olden, K. and Yamada, K. M (1987). Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J. Biol. Chem 262, 6886-6892.[Abstract/Free Full Text]
Hynes, R. O (1973). Alteration of cell surface proteins by viral transformation and by proteolysis. Proc. Nat. Acad. Sci. USA 70, 3170-3174.[Abstract/Free Full Text]
Hynes, R. O (1985). Molecular biology of fibronectin. Annu. Rev. Cell Biol 1, 67-90.
Hynes, R. O (1992). Integrins: versatility, modulation and signaling in cell adhesion. Cell 69, 11-25.[Medline]
Kornblihtt, A. R., Vibe-Pedersen, K. and Baralle, F. E (1984). Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucl. Acids Res 12, 5853-5868.[Abstract/Free Full Text]
Kornblihtt, A. R., Vibe-Pedersen, K. and Baralle, F. E (1984). Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J 3, 221-226.[Medline]
Laemmli, U. K (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 27, 680-685.
Littlefield, J. W (1964). Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science 145, 709-710.[Abstract/Free Full Text]
Magnuson, V. L., Young, M., Schattenberg, D. G., Mancini, M. A., Chen, D., Steffensen, B. and Klebe, R. J (1991). The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J. Biol. Chem 266, 14654-14662.[Abstract/Free Full Text]
Mardon, H. J., Bee, J., von der Mark, K. and Owen, M. E (1987). Development of osteogenic tissue in diffusion chambers from early precursor cells in bone marrow of adult rats. Cell Tiss. Res 25, 157-165.
Mardon, H. J. and Sebastio, G (1992). Regulation of alternative splicing in the IIICS region of human fibronectin pre-mRNA encoding cell binding sites CS1 and CS5. J. Cell Sci 103, 423-433.[Abstract]
Nicol\230, G., Salvi, S., Oliveri, G., Borsi, L., Castellani, P. and Zardi, L (1990). Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer. Cell Differ. Dev 32, 401-408.[Medline]
Norton, P. A. and Hynes, R. O (1987). Alternative splicing of chicken792fibronectin in embryos and in normal and transformed cells. Mol. Cell. Biol 7, 4297-4307.[Abstract/Free Full Text]
Oyama, F., Hirohashi, S., Shimosato, Y., Titani, K. and Sekiguchi, K (1989). Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver cells. J. Biol. Chem 264, 10331-10334.[Abstract/Free Full Text]
Oyama, F., Hirohashi, S., Shimosato, Y., Titani, K. and Sekiguchi, K (1990). Oncodevelopmental regulation of the alternative splicing of fibronectin pre-messenger RNA in human lung tissues. Cancer Res 50, 1075-1078.[Abstract/Free Full Text]
Pollack, R., Osborn, M. and Weber, K (1975). Patterns of organisation of actin and myosin in normal and transformed cultured cells. Proc. Nat. Acad. Sci. USA 994, 994-998.
Proudfoot, N. J., Rutherford, T. R. and Partington, G. A (1984). Transcriptional analysis of human-globin genes. EMBO J 3, 1533-1540.[Medline]
Punnett, H. H., Kistermacherm M. L., Greene, A. E. and Coriell, L. L (1974). An (X;1) translocation, balanced 46 chromosomes. Repository identification no. GM-97. Cytogenet. Cell Genet 13, 406-407.[Medline]
Rahilly, M. A., Salter, D. M. and Fleming, S (1991). Composition and organisation of cell-substratum contacts in normal and neoplastic renal epithelium. J. Pathol 165, 163-171.[Medline]
Rasheed, S., Nelson-Rees, W. A., Toth, E. M., Arnstein, P. and Gardner, M. B (1974). Characterisation of a newly derived human sarcoma cell line (HT-1080). Cancer 33, 1027-1033.[Medline]
Schreiner, M. F., Fisher, M., Hussein, S. and Juliano, R. L (1991). Increased tumorigenicity of fibronectin receptor deficient chinese hamster ovary cell variants. Cancer Res 51, 1738-1740.[Abstract/Free Full Text]
Schwarzbauer, J. E., Patel, R. S., Fonda, D. and Hynes, R. O (1987). Multiple sites of alternative splicing of the rat fibronectin gene transcript. EMBO J 6, 2573-2580.[Medline]
Schwarzbauer, J. E., Tamkun, J. W., Lemischka, I. R. and Hynes, R. O (1983). Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 35, 421-431.[Medline]
Sekiguchi, K., Siri, A., Zardi, L. and Hakomori, S (1985). Differences in domain structure between human fibronectins isolated from plasma andfrom culture supernatants of normal and transformed fibroblasts. J. Biol. Chem 260, 5105-5114.[Abstract/Free Full Text]
Steel, D. M. and Harris, H (1989). The effect of antisense RNA to fibronectin on the malignancy of hybrids between melanoma cells and normal fibroblasts. J. Cell Sci 93, 515-524.[Abstract/Free Full Text]
Tamkun, J. W., Schwarzbauer, J. E. and Hynes, R. O (1984). A single rat fibronectin gene generates three different mRNAs by alternative splicing of a complete exon. Proc. Nat. Acad. Sci. USA 81, 5140-5144.[Abstract/Free Full Text]
Towbin, H., Staehelin, T. and Gordon, J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Nat. Acad. Sci. USA 76, 4350-4354.[Abstract/Free Full Text]
Vartio, T., Laitinen, L., Narvanen, O., Cutolo, M., Thornel, L., Zardi, L. and Virtanen, I (1987). Differential expression of the ED sequence-containing form of cellular fibronectin in embyronic and adult human tissues. J. Cell Sci 88, 419-430.[Abstract/Free Full Text]
Vibe-Pedersen, K., Kornblihtt, A. R. and Baralle, F. E (1984). Expression of a human-globin/fibronectin gene hybrid generates two mRNAs by alternative splicing. EMBO J 3, 2511-2516.[Medline]
Wagner, D. D., Ivatt, R., Destree, A. T. and Hynes, R. O (1981). Similarities and differences between the fibronectins of normal and transformed hamster cells. J. Biol. Chem 256, 11708-11715.[Abstract/Free Full Text]
Yamada, K. M., Yamada, S. S. and Pastan, I (1976). Cell surface protein partially restores morphology, adhesiveness and contact inhibition of movement to transformed fibroblasts. Proc. Nat. Acad. Sci. USA 73, 1217-1221.[Abstract/Free Full Text]
Zajchowski, D. A., Band, V., Trask, D. K., Kling, D., Connolly. J. L. and Sager, R (1990). Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells with immortal mammary epithelial cells. Proc. Nat. Acad. Sci. USA 87, 2314-2318.[Abstract/Free Full Text]
Zardi, L., Carnemolla, B., Siri, A., Petersen, T. E., Paolella, G., Sebastio, G. and F. E. Baralle (1987). Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J 6, 2337-2342.[Medline]
